| SLS Shares Outstanding History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the SLS shares outstanding history going back to 4/6/2018:
Also see: SLS Market Cap History SLS YTD Return |
SLS Shares Outstanding History — SELLAS Life Sciences Group Share Count Over Time
As of 5/11/2026 SELLAS Life Sciences Group has 186.03 million SLS shares outstanding. Investors often track the SLS shares outstanding history to compare shareholder return trends against the change in share count over time.
This page shows SLS share count trends over time, with 33 historical shares outstanding datapoints presented, dating back to 4/6/2018.
| SLS Shares Outstanding History Chart | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
SLS Historical Shares Outstanding: +144.86% CAGR 
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| SLS Stock Price Chart |
| About SELLAS Life Sciences Group Inc |
| SELLAS Life Sciences Group, Inc. is a late-stage clinical biopharmaceutical company. Co. is focused on the development of novel therapeutics for a range of cancer indications. Co.'s product candidates, galinpepimut-S (GPS), a peptide immunotherapy directed against the Wilms tumor 1 (WT1), antigen, and SLS009, a selective small molecule cyclin-dependent kinase 9 (CDK9), inhibitor. GPS is a cancer immunotherapeutic agent licensed from Memorial Sloan Kettering Cancer Center (MSK), that targets the WT1 protein, which is present in an array of tumor types. We show 33 historical shares outstanding datapoints in our coverage of SLS's shares outstanding history. Understanding the changing numbers of SLS shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like SLS versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching SLS by allowing them to research SLS shares outstanding history as well as any other stock in our coverage universe. |
| SLS Current Stock Quote |
Quotes delayed 20 minutes  Free SLS Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: Shares Outstanding Importance | |
|
Video: Shares Outstanding Importance
| SLS Share Performance |
| Shares Outstanding Peers |
| SELLAS Life Sciences Group (SLS) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:
SMLR Shares Outstanding History SMMT Shares Outstanding History SMTI Shares Outstanding History SNBP Shares Outstanding History SNCA Shares Outstanding History SNDA Shares Outstanding History SNDX Shares Outstanding History SNES Shares Outstanding History SNGX Shares Outstanding History SNNA Shares Outstanding History More Healthcare companies » |
SLS Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2026, All Rights Reserved
Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you
agree to the following Full Disclaimer & Terms of Use and
Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at
least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
